Sorry, you need to enable JavaScript to visit this website.

Relapsed: D + RD Treatment | DARZALEX® IV (daratumumab)

DARZALEX® Treatment:

DARZALEX® in combination with Revlimid®
(lenalidomide) + dexamethasone

For adults with multiple myeloma who have received at least 1 prior medicine.

The frequency and length of DARZALEX® infusions decreases over time.

On average, the first DARZALEX® infusion may take about 7 hours. However, your doctor may choose to give the first dose as two shorter infusions over two consecutive days.

Future infusions will take less time and last 3 to 5 hours, not including check-in and check-out time. After the initial rounds, DARZALEX® treatments are needed only once every four weeks.

Median length of infusion

Other medicines in this regimen are given as follows:

  • Revlimid® (lenalidomide) by mouth on days 1-21 of each 4-week cycle*
  • dexamethasone by mouth or IV infusion once a week†
    • On DARZALEX® infusion days, a portion of the dexamethasone dose may be given as a pre-infusion medication and the remainder given the day after the infusion
    • For some patients, the entire dexamethasone dose may be given as a pre-infusion medication

*Please refer to the lenalidomide Prescribing Information for more detailed information about lenalidomide dosing.

†Your dexamethasone dosing may be modified by your doctor. Please see the DARZALEX® Prescribing Information for more information.

See how this DARZALEX® treatment regimen was studied

Create a calendar with your treatment schedule